Bei Akademie registrieren
Grifols, ES0171996087

Grifols stock slightly lower pre-market: plasma group at EUR 10.04

Published on 10/21/2026 at 08:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Grifols develops plasma-derived therapies and other healthcare products. At Lang & Schwarz the stock trades pre-market at EUR 10.04 on October 21, 2026.

Business model and market context

  • Grifols develops plasma-derived therapies and healthcare products.
  • The relevant home-market benchmark is Spain's IBEX 35.
  • Grifols stock trades pre-market at EUR 10.04 at 8:30 a.m. CEST at Lang & Schwarz on October 21, 2026.
Fotorealistische Plasma-Fraktionierungsanlage, Biotech-Produktion, unbeschriftete Industriehalle
Fotorealistische Ansicht einer Plasma-Fraktionierungsanlage zeigt Grifols S.A. ES0171996087 in moderner Biotech-Produktion mit Reinraumtechnik, Illustration mit AI erstellt.

Grifols develops and distributes therapeutic products, with a primary focus on medicines derived from human plasma. Grifols stock trades pre-market at EUR 10.04 at 8:30 a.m. CEST at Lang & Schwarz on October 21, 2026.

Ahead of the Xetra open

The pre-market indication is being monitored ahead of the Xetra open. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Grifols stock.

The group and its market

Its activities include plasma-derived medicines, hospital products, diagnostic solutions and biological materials for life-science research. Market context: Market report IBEX 35.

More news and analysis on Grifols stock

Disclaimer...
en | ES0171996087 | GRIFOLS | boerse | 70380110 | bgmi